Torii Pharmaceutical Co Ltd (4551)

Currency in JPY
6,350.0
0.0(0.00%)
Closed·
Showing Torii Pharmaceutical historical data. For real-time data please try another search
Fair Value
Day's Range
6,330.06,350.0
52 wk Range
3,795.06,470.0
Key Statistics
Bid/Ask
6,330.00 / 6,360.00
Prev. Close
6,350
Open
6,340
Day's Range
6,330-6,350
52 wk Range
3,795-6,470
Volume
-
Average Volume (3m)
51.68K
1-Year Change
72.0867%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4551 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Torii Pharmaceutical Co Ltd Company Profile

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents for renal diseases and hemodialysis, such as ENAROY tablets to treat anemia associated with CKD; Riona tablets for the treatment of hyperphosphatemia/iron deficiency anemia (IDA); and REMITCH, an oral therapeutic agent for the treatment of pruritus. The company provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; VTAMA cream, a topical treatment for atopic dermatitis and plaque psoriasis; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. It markets its products primarily through medical representatives for medical professionals. The company has a collaboration with ALK-Abelló A/S to develop and commercializes ALK’s allergen immunotherapy drug targeting pollen diseases caused by grass pollen. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc. As of September 1, 2025, Torii Pharmaceutical Co., Ltd. operates as a subsidiary of Shionogi & Co., Ltd..

Employees
592
Market
Japan

Compare 4551 to Peers and Sector

Metrics to compare
4551
Peers
Sector
Relationship
P/E Ratio
0.0x10.5x−0.6x
PEG Ratio
0.000.050.00
Price/Book
0.0x1.2x2.6x
Price / LTM Sales
0.0x1.8x3.4x
Upside (Analyst Target)
0.0%−0.3%44.9%
Fair Value Upside
Unlock2.7%6.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4551 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.